Letters from the Director Archive

October 2024 Letter from the Director

Compounding of GLP-1 Drugs

Due to the shortages of obesity medications, some patients are turning to pharmacies that produce compounded versions of these medications.

September 2024 Letter from the Director

New ICD-10 Codes for the Diagnosis of Obesity

In September 2023, the National Center for Health Statistics (NCHS) approved updated ICD-10-CM obesity codes and they go into effect on October 1, 2024.

August 2024 Letter from the Director

Guest Letter: Cardio-Kidney-Metabolic Syndrome

What you need to know about Cardio-Kidney-Metabolic Syndrome.

July 2024 Letter from the Director

What are 'Ozempic Babies' and How Does Obesity Impact Women?

Hormonal differences, like Polycystic Ovary Syndrome (PCOS), and the implications of obesity for fertility illustrate some of the ways in which women’s experiences with obesity diverge from those of men.

June 2024 Letter from the Director

Health Equity and Obesity

Researchers and public health professionals who deliver obesity care and prevention should consider the equity implications of their work.

May 2024 Letter from the Director

New Medicaid Obesity Treatment Coverage Study

Read about our new research on how state Medicaid plans cover obesity care and treatment.

April 2024 Letter from the Director

Weight Discrimination in the Workplace

How do people with obesity experience weight-based discrimination in the workplace?

March 2023 Letter from the Director

Global Obesity Guest Letter

No-Longer the “Invisible Minority:” A Billion People with Obesity, Vast Majority in Low- and Middle-Income Countries

February 2024 Letter from the Director

Obesity Care Week 2024

Learn about the five principles of obesity promoted during Obesity Care Week 2024.

January 2024 Letter from the Director

Understanding Food Noise

Weight Watchers and the STOP Obesity Alliance collaborated on a study to better understand food noise and how it impacts people with overweight and obesity.